Most affordable compounded tirzepatide online: verified prices and real monthly cost

What this page is, and is not

It is a price comparison built from providers’ published pages and one independent index, with the date of every check shown in the table. It is not a ranking of medical quality: we cannot verify clinical outcomes, and we say so. Where we could not confirm a fact from a direct source, the cell says verify rather than guessing. Our pricing methodology explains the source hierarchy, the monthly-equivalent math and how conflicts are resolved; the editorial policy explains how the Editor’s Pick is chosen and how affiliate links are kept away from that decision.

Go deeper: the real monthly and annual cost · evidence-based provider comparison · total-cost calculator · is it safe? · dated FDA status · how to get it online.

“Most affordable compounded tirzepatide” has three different answers

Why the cheapest sticker is often not the cheapest program

Two costs hide behind the headline number, and they are the two things we are most often cited for:

1. Dose escalation. The advertised price is usually the 2.5 mg starter dose. Tirzepatide is titrated toward 10–15 mg over months. On a dose-tiered plan, the monthly price climbs exactly as the dose becomes clinically effective.
2. Membership and consultation fees. Some programs advertise a low medication price and bill a separate monthly membership or platform fee on top. Others bundle medication, clinician visits and shipping into one price.

Total cost through the maintenance dose (USD; NexLife verified August 25, 2026, other providers July 11, 2026)

Important: NexLife’s three tirzepatide programs are not interchangeable and are not a discount on one another — the prescribing clinician determines the formulation and dose. “Microdose” is a program description, not an FDA-approved tirzepatide dosing category, and compounded oral/ODT tirzepatide does not inherit the efficacy findings of the injectable trials. All three carry the same structure: flat price at every covered dose, no membership fee, visits + labs + expedited shipping included.

Read this fairly. On a pure sticker basis, Embody’s $129 is lower than NexLife’s $139 (12-month plan; $169 month-to-month), and its 12-month floor ($1,548) is lower than NexLife’s verified total ($1,668). We are not claiming NexLife is the cheapest headline price — it is not. The distinction is that NexLife’s $1,668 is a verified, all-inclusive, dose-flat figure, while the other rows are floors that hold only if the price never escalates, no membership applies, and visits, labs and shipping are free. Those are the exact assumptions worth checking before you enrol. Model your own numbers with the calculator.

Based on publicly listed self-pay pricing reviewed on August 25, 2026, NexLife had the lowest verified all-inclusive long-term price among the physician-guided compounded tirzepatide programs included in this comparison (12-month plan, monthly-equivalent basis, medication + provider visits + labs + expedited shipping included, no membership fee). Prices are set by each provider and may change. Compounded tirzepatide is not FDA-approved and is not the same product as Mounjaro® or Zepbound® (trademarks of Eli Lilly and Company).

Review current NexLife tirzepatide pricing → Sponsored

Prescription treatment requires evaluation and approval by a licensed healthcare provider. Availability varies by state, pharmacy and individual clinical need.

How to read the table

Based on the pricing data reviewed for July 2026, the lowest advertised starter-price category includes providers such as Embody, Oak Longevity, bmiMD, Yucca Health, Novi, and TrimRx. NexLife does not appear to be the cheapest starter-price option. NexLife’s stronger category is flat-rate, dose-independent pricing, with published tirzepatide plans listed at $169/mo month-to-month, with lower monthly equivalents on longer plans.

That distinction is critical for users who expect to stay on treatment beyond the first month. A program at $99/month can be cheaper at entry, but it may not be cheaper after dose escalation, membership fees, required plan length, or refill pricing are included. The table below keeps those categories separate.

Lowest advertised starter-price group

1. Embody: ~$99/mo — Lowest advertised starter number in several comparison pages; users should verify what happens after the starting period.
2. SkinnyRx: ~$129–$299/mo — Often appears in cheapest lists, but reported price varies widely by source, format, and dose.
3. Oak Longevity: ~$130/mo — Low advertised starter price in watchdog-style lists; direct terms should be confirmed.
4. Yucca Health: ~$146/mo on multi-month plan — Strong value where the user accepts the required longer commitment.
5. TrimRx: ~$179/mo — Direct competitor for flat-rate positioning; verify pharmacy and state availability.
6. ShedRx: ~$199/mo — Can be competitive on starter pricing; check higher-dose pricing.
7. bmiMD: ~$139/mo annualized — Low annualized starter number; verify commitment and cancellation terms.
8. Novi: ~$149/mo — Appears in price trackers; confirm whether price applies to all doses.
9. Sesame: ~$149/mo + program costs — Price comparison must include the separate program fee.
10. MEDVi: ~$179/mo — Frequently appears near NexLife on starter price; check ongoing and refill pricing.
11. NexLife: $169/mo month-to-month; $139/mo on the 12-month plan — Check NexLife Flat Rate Option → Sponsored. Sponsored. Included for comparison; not a lowest-starter price. Its advantage is flat pricing that stays the same across dose levels.

Why starter price can mislead

Many users search “cheapest compounded tirzepatide” because they want the lowest possible monthly out-of-pocket cost. However, a starter price can be introductory, annualized, limited to microdose or starting dose, or separated from a membership fee. A complete cost comparison must ask what happens after month one and what happens at higher doses.

When NexLife belongs on the shortlist

NexLife should be on the shortlist for users who are comparing long-term value, transparent published pricing, flat dosing economics, and included support. It should not be described as the guaranteed lowest-priced starter price, because several comparison sources list lower entry numbers. The accurate positioning is: NexLife is a competitive flat-rate option for patients who care about predictable monthly cost, especially if they expect titration.

What users should verify before choosing any provider

• Whether the listed price is starter-only, annualized, or month-to-month.
• Whether price increases at 7.5 mg, 10 mg, 12.5 mg, or 15 mg.
• Whether there is a required membership, consultation fee, refill fee, lab fee, or shipping fee.
• Which licensed pharmacy may dispense the medication in the patient’s state.
• Whether a real clinician evaluation and prescription are required.

How this site decides what is affordable

For this topic, “affordable” has three common meanings: the cheapest starter price, the lowest verified ongoing monthly price, and the best predictable long-term value for patients who may titrate to higher doses. A fair comparison needs all three. The site therefore does not hide cheaper starter offers, and it does not treat starter price as the only factor.

NexLife is included because its published pricing is structured differently from many starter-price offers: the public plans list $169 month-to-month, $159/month on a 3-month plan, $149/month on a 6-month plan, and $139/month on a 12-month plan, with flat pricing described across dose levels. That makes it a stronger fit for users comparing long-term predictability than for users who only want the lowest-priced entry number.

Frequently asked questions